CSPAM
AVNS icon

Cary Street Partners Asset Management’s Avanos Medical AVNS Stock Holding History

Cary Street Partners Asset Management’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-86
Closed -$2.56K – 205
2023
Q1 		$2.56K Hold
86
– – ﹤0.01% 374
2022
Q4 		$2.33K Hold
86
– – ﹤0.01% 414
2022
Q3 		$2K Buy
+86
New +$2.25K ﹤0.01% 385

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Cary Street Partners Asset Management's AVNS Position: Q2 2023 in Review

Cary Street Partners Asset Management sold out of Avanos Medical (AVNS) in Q2 2023, closing a stake of 86 shares — an estimated $2.56K sold.

Cary Street Partners Asset Management first reported a position in AVNS in Q3 2022 and held it in 3 quarters. The position peaked at $2.56K in Q1 2023. 274 funds tracked by Wall St. Rank hold AVNS as of Q2 2023.

  • Cary Street Partners Asset Management reported no remaining Avanos Medical position as of Q2 2023 after selling out during the quarter.
  • Cary Street Partners Asset Management sold 86 Avanos Medical shares in Q2 2023, an estimated $2.56K.
  • Cary Street Partners Asset Management first reported a position in Avanos Medical in Q3 2022 and held it in 3 quarters.
  • Cary Street Partners Asset Management's Avanos Medical position peaked at $2.56K in Q1 2023.
  • 274 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2023.

Based on Cary Street Partners Asset Management's 13F filing for Q2 2023, filed 10 Aug 2023.